1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
2. zur Hausen H. Papillomaviruses in human cancer. Proc Assoc Am Phys 1999; 111: 581-587.
3. Remmink AJ, Walboomers JM, Helmerhorst TJ, Voorhorst FJ, Rozendaal L, Risse EK, Meijer CJ, Kenemans P. The presence of persistant high risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995; 61: 306-311.
4. Wallin K-L, Wiklund F, Angstrom T, Bergman F, Stendhal U, Wadell G, Hallmans G, Dillner J. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999; 341: 1633-1638.
5. Schneider A, Zahm DM, Kirchmayr R, Schneider V. Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytology study, cervicography and human papillomavirus detection. Am J Obstet Gynecol 1996; 174: 1534-1541.
6. Rozendaal L, Walboomers, JMM, van der Linden JC, Voorhorst, FJ, Kenemans p, Helmerhorst TJM, Vanballegooijen M, Mauer CJLM. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 1996; 68: 766-769.
7. Cuzick J, Sasieni P, Daviens P, Adams J, Normand C, Frater A, van Ballegooijen M, van den Akker E. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Asses 1999; 3: 196.
8. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 1995; 87: 796-802.
9. Chan S-Y, Delius H, Halpern AI, Bernard H-U. Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny, and taxonomy. J Virol 1995; 69: 3074-3083.
10. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992; 79: 328-337.
11. Resnick RM, Cornelissen TE, Wright DK, Greg HE, Fox HS, Schegget J, Manos MM. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990; 82: 1477-1484.
12. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989; 7: 209-214.
13. Bernard H-U, Chan SY, Manos MM, Ong C-K, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM. Identification and assesment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment polymorphisms, nucleotide sequence and phylogenic algorithms. J Infect Dis 1994; 170: 1077-1085.
